Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Semaglutide helps obese PCOS patients lose weight and improve health.

Zinc supplements may help reduce hair loss caused by levetiracetam without affecting seizure control.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Combining lifestyle changes with personalized medication is crucial for better managing obesity in PCOS.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Semaglutide does not significantly increase the risk of hair loss.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Epimorphin helps start hair growth in mice.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

GLP-1RA therapy may increase the risk of hair loss.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

A sphingolipid from human placenta may help treat vitiligo by activating melanocyte stem cells.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Tofacitinib significantly improved skin and hair conditions without side effects.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

A synthetic octapeptide may help promote hair growth and counteract hair loss.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Mimosine from lamtoro leaf powder is less harmful to the pancreas than pure mimosine.

Ritlecitinib can help about 14,000 people with severe hair loss.